Biotechnology

Filter

Current filters:

None

Popular Filters

1964 to 1988 of 2478 results

Germany seeks closer partnership with Japan in biopharmaceuticals

08-10-2012

Germany Trade & Invest (GTI) and the Health - Made in Germany initiative will join forces at this year's…

Asia-PacificBiotechnologyEuropeLicensingResearch

Industry and government cooperate to stimulate biotech clinical trials in Italy

08-10-2012

In Italy last week, the Director General of AIFA (Agenzia Italiana del Farmaco) Luca Pani, the president…

BiotechnologyEuropeRegulationResearch

UK's NICE draft guidance backs NHS use of Lucentis in DME

05-10-2012

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE), in new draft guidance…

BiotechnologyEuropeLucentisNovartisOphthalmicsPharmaceuticalPricingRegulation

"Sandoz will be the leading biosimilars company in 2012," says Visiongain

04-10-2012

Sandoz, the generics unit of Swiss drug major Novartis (NVN: VX), will retain its position as the global…

BiotechnologyDr Reddy's LaboratoriesGenericsGlobalHospiraMarkets & MarketingNovartisSandoz

New US bill would provide exclusivity add-on for significant drug combos

04-10-2012

Legislation co-sponsored in the USA by Representatives Brian Bilbray (Republican, California), Carolyn…

BiotechnologyLegalNorth AmericaPharmaceuticalRegulation

New Canadian rare disease strategy welcomed as offering hope and solutions for patients

04-10-2012

The Canadian government this week announced a new national framework to improve access to "orphan drugs"…

BiotechnologyNorth AmericaPharmaceuticalRare diseasesRegulationResearch

European Commission looks for feedback on pediatric regulation experience

04-10-2012

The European Commission has launched a public consultation on the experience gained with the paediatric…

BiotechnologyEuropePharmaceuticalRegulationResearch

Sarepta rockets as eteplirsen seen to significantly benefit Duchenne patients

04-10-2012

US RNA-based drug developer Sarepta Therapeutics (Nasdaq: SRPT) saw its shares rocket 200% to $44.93…

BiotechnologyeteplirsenPharmaceuticalRare diseasesResearchSarepta Therapeutics

Celgene's Abraxane meets main goal in melanoma trial; reviews nanomedicines

04-10-2012

Celgene International Sarl, a subsidiary of the USA's Celgene Corp (Nasdaq: CELG) has announced results…

AbraxaneBiotechnologyCelgeneOncologyPharmaceuticalResearch

French drugmaker Aguettant takes majority stake in PX'Therapeutics

03-10-2012

Aguettant Sante, a French biotechnology pioneer in drugs for injection since 1903, has acquired a majority…

AguettantBiotechnologyMergers & AcquisitionsPX'Therapeutics

Personalized medicine's transformation of health care accelerates, says Burrill

03-10-2012

The life sciences sector continued to outperform the broader markets in September, but developments during…

BiotechnologyHealthcareNorth AmericaPharmaceuticalResearch

Early-stage cholesterol drug offers new hope for patients resistant to statins

03-10-2012

A study published in The Lancet found that participants in a Phase I clinical trial saw their level of…

ALN-PCSAlnylam PharmaceuticalsBiotechnologyCardio-vascularResearch

ArQule and Daiichi Sankyo drop tivantinib trial in NSCLC

03-10-2012

USA-based drug developer ArQule (Nasdaq: ARQL) saw its shares plunge 62% to $1.90 after, along with its…

ArQuleBiotechnologyDaiichi SankyoOncologyPharmaceuticalResearchtivantinib

USA's PDUFA V sets new course for regulatory science, say BIO and PhRMA

02-10-2012

With the implementation of the USA's Prescription Drug User Fee Act (PDUFA V) on Monday, trade groups…

BiotechnologyFinancialNorth AmericaPharmaceuticalRegulation

1964 to 1988 of 2478 results

Back to top